Trial Profile
Assessment of Initial Oral Vinorelbine Dosing Schedules Used for the Treatment of Advanced Non-small-cell Lung Cancer and Metastatic Breast Cancer in Clinical Routine in Germany and Austria (StepUp)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2018
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Advanced breast cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms StepUp
- Sponsors Pierre Fabre
- 28 Aug 2018 Status changed from active, no longer recruiting to completed.
- 07 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 26 Sep 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.